These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18452071)

  • 21. Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome.
    Sefcick A; Sowter D; DasGupta E; Russell NH; Byrne JL
    Br J Haematol; 2004 Feb; 124(4):558-9. PubMed ID: 14984510
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of mycosis fungoides with PUVA.
    Hönigsmann H; Tanew A; Wolff K
    Photodermatol; 1987 Feb; 4(1):55-8. PubMed ID: 3615250
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis.
    Ayasse M; Nelson K; Glass F; Silverberg JI
    Dermatitis; 2021 Oct; 32(1S):e88-e89. PubMed ID: 33273230
    [No Abstract]   [Full Text] [Related]  

  • 24. Sustained, durable responses with alemtuzumab in refractory angioimmunoblastic T-cell lymphoma.
    Amengual JE; Raphael BG
    Leuk Lymphoma; 2010 Jul; 51(7):1347-50. PubMed ID: 20572801
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides.
    Papalas JA; Sebastian S; Wang E
    Leuk Lymphoma; 2011 May; 52(5):905-7. PubMed ID: 21299463
    [No Abstract]   [Full Text] [Related]  

  • 26. DAT-negative hemolytic anemia in a chronic lymphocytic leukemia patient treated with alemtuzumab.
    d'Arena G; de Filippi R; Pinto A
    Leuk Lymphoma; 2007 Mar; 48(3):625-7. PubMed ID: 17454610
    [No Abstract]   [Full Text] [Related]  

  • 27. [A case of mycosis fungoides with pulmonary involvement: effect of etoposide and prednisolone].
    Nasuhara Y; Kobayashi S; Munakata M; Kawakami Y; Fujita M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep; 33(9):1013-8. PubMed ID: 8538082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comment on alemtuzumab and inclusion body myositis.
    Greenberg SA
    Brain; 2010 May; 133(Pt 5):e135; author reply e136. PubMed ID: 19892769
    [No Abstract]   [Full Text] [Related]  

  • 29. Alemtuzumab in kidney-transplant recipients.
    Luan FL
    N Engl J Med; 2011 Aug; 365(7):671; author reply 671-2. PubMed ID: 21848469
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
    Laurenti L; Tarnani M; Innocenti I; Savino G; Battendieri R; Larocca LM; Chiusolo P; Sorà F; Sica S; Efremov D; Leone G
    J Clin Oncol; 2008 Nov; 26(32):5299-301. PubMed ID: 18854557
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical characteristics of mycosis fungoides].
    Koliadenko VG; Golovchenko DIa; Shmyglo MP; Fedorenko AE
    Vestn Dermatol Venerol; 1982 Nov; (11):49-51. PubMed ID: 7158003
    [No Abstract]   [Full Text] [Related]  

  • 32. Dupilumab, Atopic Dermatitis, and Mycosis Fungoides-New Insights on an Evolving Story.
    Guitart J
    JAMA Dermatol; 2023 Nov; 159(11):1177-1178. PubMed ID: 37851433
    [No Abstract]   [Full Text] [Related]  

  • 33. Poikilodermatous mycosis fungoides.
    Farley-Loftus R; Mandal R; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosing mycosis fungoides after initiation of therapy with dupilumab: a case report and literature review.
    Yan D; Ramachandran V; Weston G; Kim RH; Latkowski JA
    Int J Dermatol; 2023 Sep; 62(9):e500-e503. PubMed ID: 36946434
    [No Abstract]   [Full Text] [Related]  

  • 35. [Involvement of inner organs in the course of mycosis fungoides].
    Molak-Olczakowa H; Kostanecki W; Dabrowski J
    Przegl Dermatol; 1976; 63(2):191-8. PubMed ID: 1265307
    [No Abstract]   [Full Text] [Related]  

  • 36. Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides.
    Wang J; Ram-Wolff C; Dobos G; Al Hage J; Grange F; Rivet J; Vignon-Pennamen MD; Moins-Teisserenc H; Boisson M; Moegle C; Sadoux A; Mourah S; Battistella M; Bagot M; de Masson A
    Br J Dermatol; 2022 Jul; 187(1):129-131. PubMed ID: 35083741
    [No Abstract]   [Full Text] [Related]  

  • 37. Alemtuzumab for refractory celiac disease.
    Verbeek WH; Mulder CJ; Zweegman S
    N Engl J Med; 2006 Sep; 355(13):1396-7; author reply 1397. PubMed ID: 17005966
    [No Abstract]   [Full Text] [Related]  

  • 38. The prevention of alemtuzumab-induced cytomegalovirus reactivation: still a matter of debate. An update from Pesaro experience with once weekly intravenous ganciclovir.
    Isidori A; Visani G
    Leuk Lymphoma; 2009 Feb; 50(2):294-6. PubMed ID: 19197728
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cardiac involvement in mycosis fungoides].
    Fritz GA; Mohadjer D; Schaffler G; Reittner P
    Rofo; 2006 Sep; 178(9):918-9. PubMed ID: 16894505
    [No Abstract]   [Full Text] [Related]  

  • 40. Mycosis fungoides bullosa.
    Natsuga K; Shimizu T; Abe R; Kodama K; Shimizu H
    Arch Dermatol; 2006 Jun; 142(6):793-5. PubMed ID: 16785397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.